No cases of CRS greater than grade 2 were seen in any ... ARX517 showed encouraging phase 1/2 safety and efficacy results at last year’s ESMO congress. Meanwhile, Janux also reported early ...

Shares of Sutro Biopharma (NASDAQ:STRO) fell by 17% in September after the company's ESMO (European Society for Medical Oncology) update. 3-year performance isn't looking much better at -81% ...

Here you will find news stories and blog posts about the research our scientists have presented at the congress over the years. ESMO Virtual Plenary 2022: Major trial shows targeted drug improves ...

Being an antibody-based therapy, Polivy does not produce the extreme side effects seen with CAR-T either, such as neurotoxicity and cytokine release syndrome (CRS). Roche said adverse reactions ...

System Restore is a long-standing feature on Windows 11. Its purpose is to create snapshots of the computer's current working state and save them as "restore points" when specific events are ...

Community Bank System, Inc. is a holding company, which engages in the provision of retail, business, and municipal banking services. It operates through the following segments: Banking, Employee ...

Immunocore reports third quarter financial results and provides a business updateKIMMTRAK® (tebentafusp-tebn) net revenues of $80.2 million in 3Q ...

As it turns out, some terms that describe a phone’s ruggedness are actually standardized, and there’s a whole lot more to them than meets the eye. IP ratings measure a device’s resistance to ...

Credit scores range from 300 to 850. Those three digits might seem arbitrary, but they matter — a lot. A good credit score is key to qualifying for the best credit cards, mortgages and ...

“Lobular has now been featured at all the major conferences — ESMO, ASCO, SABCS and others,” he said. “But we need more money and we need much more research.” While the loss of E-cadherin underpins ...

MediLink has announced the data of a Phase I/II clinical trial of YL201 in patients with advanced solid tumors including SCLC as a selected oral presentation at the ESMO Congress 2024. This ...

LUND, SWEDEN / ACCESSWIRE / October 31, 2024 / BioInvent International (STO:BINV) "Progress to date brings the company one step closer to addressing the needs for new treatment solutions for patients.